David M. Spencer
Geen lopende functies
Oorsprong van het eerstegraads netwerk van David M. Spencer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Private Company | Biotechnology | 35 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David M. Spencer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Applied Immune Sciences, Inc.
 Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
| OSIRIS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer Corporate Officer/Principal Chief Executive Officer | |
| MARKER THERAPEUTICS, INC. | Biotechnology | General Counsel Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Rice University | College/University | Undergraduate Degree Undergraduate Degree | |
Promega Corp.
 Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Biotechnology | Corporate Officer/Principal | |
McDermott Will & Emery LLP
 McDermott Will & Emery LLP Miscellaneous Commercial ServicesCommercial Services McDermott Will & Emery LLP provides legal services. The company's practices include corporate, employee benefits, health law, intellectual property, private clients, regulation and government affairs, tax, and trial. The company was founded in 1934 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Graduate Degree Undergraduate Degree | |
| Knox College | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Graduate Degree | |
| Murray State University (Kentucky) | College/University | Undergraduate Degree | |
| The University of Colorado | College/University | Masters Business Admin | |
| Utah State University | College/University | Doctorate Degree Doctorate Degree | |
| Weber State University | College/University | Undergraduate Degree | |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| Baylor College of Medicine | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Biotechnology | Chief Executive Officer General Counsel President | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Repair Technologies, Inc. | General Counsel Chief Executive Officer | ||
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
| Georgetown University Law Center | College/University | Graduate Degree | |
| Washington University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Chief Operating Officer | |
| LANDMARK INFRASTRUCTURE PARTNERS LP | Real Estate Development | Director/Board Member | |
Pacific GeneTech Ltd.
 Pacific GeneTech Ltd. BiotechnologyHealth Technology Pacific GeneTech Ltd. is a biotech company based in Hong Kong, Hong Kong. Pacific GeneTech develops and commercializes next-generation vaccines and biologics for areas of high unmet or underserved needs in food safety and animal health. The Chinese company's proprietary "Aegis" vaccine platform combines cross-protective antigens and immunopotentiators in PGT vectors for broad-spectrum protection against multiple strains and species of infectious diseases. PGT has out-licensed its adjuvant for use in third-party vaccines and is developing broad applications for its adjuvant/delivery system. The private company's "Hercules" adjuvant/delivery system provides enhanced efficacy of inactivated and DNA vaccines, and its "Argo" yeast vector is a safe, flexible, and robust carrier of immunogenic material. PGT has out-licensed two of its leading poultry vaccines addressing economically important gastro-intestinal pathogens and has out-licensed its Hercules adjuvant for use in third-party vaccines. Vaccines for other pathogens and animal species are under development, including an experimental DNA vaccine for African swine fever. PGT is developing other applications for its Hercules adjuvant/delivery system and for the Argo vector. The company, through its affiliate company, PGTX, has commenced programs with collaborators addressing human dysentery and related diseases, and malaria. The company was founded in 2009, and the CEO is Tim Collard. | Biotechnology | Director/Board Member | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Biotechnology | Founder Human Resources Officer | |
Sidley Austin LLP
 Sidley Austin LLP Miscellaneous Commercial ServicesCommercial Services Sidley Austin LLP is a premier legal adviser with over 2000 lawyers in 20 offices worldwide. Sidley Austin is based in Chicago, IL and has subsidiaries in Germany, Hong Kong, United States, United Kingdom, and Japan. The firm has been providing superior client service for over 150 years and has a diverse group of legal professionals from many cultures who are dedicated to teamwork and collaboration. Sidley Austin has forged enduring relationships with the business community and serves a varied and high-caliber group of market leaders, many of whom are pioneers in their respective industries and professions. The firm is committed to pro bono service and its lawyers and staff devote more than 100,000 hours annually to serving those most in need. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 50 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 2 |
Operationeel
| Corporate Officer/Principal | 86 |
| Director/Board Member | 80 |
| Undergraduate Degree | 34 |
| Independent Dir/Board Member | 28 |
| Chief Tech/Sci/R&D Officer | 26 |
Sterkste connecties
| Insiders | |
|---|---|
| James Farrell Brown | 20 |
| Kevin M. Slawin | 20 |
| Reid Huber | 16 |
| Alan Musso | 15 |
| William Grossman | 13 |
| James Daly | 13 |
| Dennis K. Stone | 12 |
| Peter Hoang | 12 |
| Alan K. Smith | 12 |
| Kenneth Ray Moseley | 12 |
| Annemarie B. Moseley | 12 |
| Stephen Davis | 11 |
| Shane Ward | 10 |
| Edmund Harrigan | 10 |
| Jon Stonehouse | 10 |
- Beurs
- Insiders
- David M. Spencer
- Bedrijfsconnecties
